30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Episurf Medical Patent and Regulatory Updates -

Episurf Medical received an additional patent in China relative to the Episealer® Femoral Twin joint implant design process, entitled “Surgical kit for cartilage repair comprising implant and a set of tools,” relative to the Episealer® Femoral Twin joint implant and its design process. The company expects to obtain CE Mark Approval for the Episealer® Talus ankle implant within coming weeks. The implant is intended for osteochondral lesions of the talar dome. Talus implants are based on the same technology platform as the Episealer knee devices, with an individualized design based on medical imaging and 3D modulation. The company has a parallel process to receive CE Mark approval for an individualized osteotomy guide for use in medial malleolar osteotomies.